Miriam A. Bornhorst

Hematology | Oncology
225 E Chicago Ave
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.

Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.

Journal: Neuro-oncology advances
Published: April 27, 2026

Long-Term Hematologic Effects of Selumetinib Treatment in Children With Neurofibromatosis Type 1-Associated Plexiform Neurofibromas.

Long-Term Hematologic Effects of Selumetinib Treatment in Children With Neurofibromatosis Type 1-Associated Plexiform Neurofibromas.

Journal: Pediatric blood & cancer
Published: April 02, 2026

The 9th International RASopathies Symposium.

The 9th International RASopathies Symposium.

Journal: American journal of medical genetics. Part A
Published: February 25, 2026

The Role of "Adult-Onset" Cancer Predisposition Genes in Pediatric Cancer: A Comprehensive Review.

The Role of "Adult-Onset" Cancer Predisposition Genes in Pediatric Cancer: A Comprehensive Review.

Journal: Pediatric blood & cancer
Published: February 05, 2026

MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies.

MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies.

Journal: Cells
Published: October 09, 2025

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.

Journal: Nature communications
Published: February 21, 2025

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.

Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025

The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma.

The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma.

Journal: Human genetics
Published: November 25, 2024

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 08, 2024

Tumor volume features predict survival outcomes for patients diagnosed with diffuse intrinsic pontine glioma.

Tumor volume features predict survival outcomes for patients diagnosed with diffuse intrinsic pontine glioma.

Journal: Neuro-oncology advances
Published: October 22, 2024

Early prognostication of overall survival for pediatric diffuse midline gliomas using MRI radiomics and machine learning: A two-center study.

Early prognostication of overall survival for pediatric diffuse midline gliomas using MRI radiomics and machine learning: A two-center study.

Journal: Neuro-oncology advances
Published: July 19, 2024

Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers.

Zebrafish-A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers.

Journal: Cancers
Published: March 15, 2024
Showing 1-12 of 49

Last Updated: 09/26/2026